Locations:
Search
Risk of new MS activity is small in those older than 55 with stable disease who stop MS therapy
Insights from 15 years of experience of Cleveland Clinic’s spine tumor board
Two-year trial results find Total Posterior Spine System to be safe and effective
Growing public interest in hallucinogens highlights their therapeutic promise and potential perils
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Minimally invasive approach is gaining prominence as a fast and safe outpatient procedure
Novel research is comparing sleep measures to biomarkers of neurodegeneration
For patients with moderate to severe OSA who are intolerant of traditional CPAP therapy, HNS may provide a welcome improvement to QoL
Plasma proteome analysis aimed at identifying candidate blood-based biomarkers in women
IV thrombolysis should not be delayed because of planned thrombectomy
Insights on integrating behavioral health providers into care as the disease progresses
Advertisement
Advertisement